Hyperhomocysteinemia: An important risk factor for cardiovascular disease? Potentially, yes

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 9, 2003, Pages 1878-1879

  Cattaneo, M ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; HUMAN; HYPERHOMOCYSTEINEMIA; MASS SCREENING; NOTE; RISK FACTOR; TREATMENT OUTCOME;

CARDIOVASCULAR DISEASES; HUMANS; HYPERHOMOCYSTEINEMIA; MASS SCREENING; RISK FACTORS; TREATMENT OUTCOME;

EID: 2442590989     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00403.x     Document Type: Article

References (13)

1. Cattaneo M. Hyperhomocysteinemia and thrombosis. Lipids 2001; 36 (Suppl.): SI3-26.
2. Homocysteine and risk of ischemie heart disease and stroke: a meta-analysis, JAMA, The Homocysteine Stuides Collaboration 2002; 288: 2015-22
3. Epstein FH. The epidemiology of coronary heart disease: a review. J Chronic Dis 1965; 18: 735-74.
4. Wilhelmsen L, Wedel H, Tibbins G. Multivariate analysis of risk factors for coronary heart disease. Circulation 1973; 48: 950-8.
5. Rabkin SW, Sackett DL. Arterial thromboembolism. Epidemiology. In: Colman RW, Hirsh J, Marder VJ, Salzman EW, eds. Hemostasis and Thrombosis. Basic Principles and Clinical Practice. Philadelphia: J.B. Lippincott, 1987: 1273-89.
6. Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Schouten EG. MTHFR 677C(→T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA 2002; 288: 2023-31.
7. Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 2002; 325: 1202.
8. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, den Heijer M, Kluijtmans LA, van den Heuvel LP et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenete-trahydrofolate reductase. Nat Genet 1995; 10: 111-3.
9. Brattstrom L, Wilcken DE, Ohrvik J, Brudin L. Common methylenete-trahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease, the result of a meta-analysis. Circulation 1998; 98: 2520-6.
10. Yap S, Boers GHJ, Wilcken B, Wilcken DEL, Brenton DP, Lee PJ, Walter JH, Howard PM, Naughten ER. Vascular outcome in patients with homocystinuria due to cystathionine {beta}-synthase deficiency treated chronically: a multicenter observational study. Arteriosclerosis, Thrombosis, Vascular Biol 2001; 21: 2080-5.
11. Lowering blood homocysteine with folic acid based supplements, meta-analysis of randomised trials. Homocysteine Lowering Trialists' Collaboration. BMJ, Homocysteine Lowering Trialists' Collaboration 1998; 316: 894-8.
12. Malinow MR, Bostom AG, Krauss RM. Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 1999; 99: 178-82.
13. Cattaneo M. Homocysteine and cardiovascular diseases. Circulation 1999; 100: el51.